Status:
COMPLETED
Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)
Lead Sponsor:
Organon and Co
Conditions:
Hyperlipidemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is intended to allow physicians to check the superior clinical efficacy of Vytorin compared to atorvastatin, as the most adequate therapy using the ATP-III goals achievement and cardiovascu...
Eligibility Criteria
Inclusion
- Patients Who Voluntary Accept To Participate In The Study After Been Informed By The Doctor And Signed The Informed Consent Form.
Exclusion
- Any Another Kind Of Contraindication For Use Of Statins
- Hypersensitivity To Any Of The Active Ingredients
- Increased Serum Hepatic Enzymes (Over 3 Times Only)
- Patients With Severe Hepatic Insufficiency
- Women who are Pregnant or Potentially Pregnant
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2005
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00651560
Start Date
November 1 2005
End Date
December 23 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.